Literature DB >> 15761666

Emerging roles of thioredoxin cycle enzymes in the central nervous system.

A Patenaude1, M R V Murthy, M-E Mirault.   

Abstract

The thioredoxins (Trxs) constitute a family of enzymes which catalyze the reduction of protein disulfide bonds. Recent animal studies have revealed the importance of the Trx superfamily in various experimental systems. For example, the homozygous disruption of the genes encoding cytoplasmic (TRX1) or mitochondrial Trx (TRX2) in mice generates lethal embryonic phenotypes. In contrast, transgenic mice overexpressing TRX1 show an extended life span and are relatively resistant to ischemia- mediated brain damage. In addition to their capacity to detoxify peroxides in concert with peroxiredoxins and Trx reductases, Trx isozymes perform multiple redox signaling functions mediated by their specific interaction with various proteins, including redox-regulated kinases and transcription factors. Recent studies indicate that specific isoforms of Trx cycle enzymes, targeted to different cell compartments, are key regulators of fundamental processes, such as gene expression, cell growth and apoptosis. The present review is primarily focused on the emerging neuroprotective role of these proteins in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15761666     DOI: 10.1007/s00018-005-4541-5

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  41 in total

1.  Timing of aspirin administration as a determinant of survival of patients with acute myocardial infarction treated with thrombolysis.

Authors:  Dov Freimark; Shlomo Matetzky; Jonathan Leor; Valentina Boyko; Israel M Barbash; Solomon Behar; Hanoch Hod
Journal:  Am J Cardiol       Date:  2002-02-15       Impact factor: 2.778

2.  Diagnosis of Myocardial Infarction Using a High-Sensitivity Troponin I 1-Hour Algorithm.

Authors:  Johannes Tobias Neumann; Nils Arne Sörensen; Tjark Schwemer; Francisco Ojeda; Rafael Bourry; Vanessa Sciacca; Sarina Schaefer; Christoph Waldeyer; Christoph Sinning; Thomas Renné; Martin Than; William Parsonage; Karin Wildi; Nataliya Makarova; Renate B Schnabel; Ulf Landmesser; Christian Mueller; Louise Cullen; Jaimi Greenslade; Tanja Zeller; Stefan Blankenberg; Mahir Karakas; Dirk Westermann
Journal:  JAMA Cardiol       Date:  2016-07-01       Impact factor: 14.676

3.  Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes.

Authors:  Gilles Montalescot; Leonardo Bolognese; Dariusz Dudek; Patrick Goldstein; Christian Hamm; Jean-Francois Tanguay; Jurrien M ten Berg; Debra L Miller; Timothy M Costigan; Jochen Goedicke; Johanne Silvain; Paolo Angioli; Jacek Legutko; Margit Niethammer; Zuzana Motovska; Joseph A Jakubowski; Guillaume Cayla; Luigi Oltrona Visconti; Eric Vicaut; Petr Widimsky
Journal:  N Engl J Med       Date:  2013-09-01       Impact factor: 91.245

4.  Effect of platelet inhibition with cangrelor during PCI on ischemic events.

Authors:  Deepak L Bhatt; Gregg W Stone; Kenneth W Mahaffey; C Michael Gibson; P Gabriel Steg; Christian W Hamm; Matthew J Price; Sergio Leonardi; Dianne Gallup; Ezio Bramucci; Peter W Radke; Petr Widimský; Frantisek Tousek; Jeffrey Tauth; Douglas Spriggs; Brent T McLaurin; Dominick J Angiolillo; Philippe Généreux; Tiepu Liu; Jayne Prats; Meredith Todd; Simona Skerjanec; Harvey D White; Robert A Harrington
Journal:  N Engl J Med       Date:  2013-03-10       Impact factor: 91.245

5.  Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial.

Authors:  Antonio L Dans; Stuart J Connolly; Lars Wallentin; Sean Yang; Juliet Nakamya; Martina Brueckmann; Michael Ezekowitz; Jonas Oldgren; John W Eikelboom; Paul A Reilly; Salim Yusuf
Journal:  Circulation       Date:  2012-12-27       Impact factor: 29.690

6.  Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease.

Authors:  Torbjørn Omland; Marc A Pfeffer; Scott D Solomon; James A de Lemos; Helge Røsjø; Jūratė Šaltytė Benth; Aldo Maggioni; Michael J Domanski; Jean L Rouleau; Marc S Sabatine; Eugene Braunwald
Journal:  J Am Coll Cardiol       Date:  2013-02-13       Impact factor: 24.094

7.  Population trends in the incidence and outcomes of acute myocardial infarction.

Authors:  Robert W Yeh; Stephen Sidney; Malini Chandra; Michael Sorel; Joseph V Selby; Alan S Go
Journal:  N Engl J Med       Date:  2010-06-10       Impact factor: 91.245

8.  Long-term use of ticagrelor in patients with prior myocardial infarction.

Authors:  Marc P Bonaca; Deepak L Bhatt; Marc Cohen; Philippe Gabriel Steg; Robert F Storey; Eva C Jensen; Giulia Magnani; Sameer Bansilal; M Polly Fish; Kyungah Im; Olof Bengtsson; Ton Oude Ophuis; Andrzej Budaj; Pierre Theroux; Mikhail Ruda; Christian Hamm; Shinya Goto; Jindrich Spinar; José Carlos Nicolau; Robert G Kiss; Sabina A Murphy; Stephen D Wiviott; Peter Held; Eugene Braunwald; Marc S Sabatine
Journal:  N Engl J Med       Date:  2015-03-14       Impact factor: 91.245

9.  C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study.

Authors:  Sohail Q Khan; Onkar S Dhillon; Russell J O'Brien; Joachim Struck; Paulene A Quinn; Nils G Morgenthaler; Iain B Squire; Joan E Davies; Andreas Bergmann; Leong L Ng
Journal:  Circulation       Date:  2007-04-09       Impact factor: 29.690

10.  Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study.

Authors:  Martin Möckel; Julia Searle; Christian Hamm; Anna Slagman; Stefan Blankenberg; Kurt Huber; Hugo Katus; Christoph Liebetrau; Christian Müller; Reinhold Muller; Philipp Peitsmeyer; Johannes von Recum; Milos Tajsic; Jörn O Vollert; Evangelos Giannitsis
Journal:  Eur Heart J       Date:  2014-04-30       Impact factor: 29.983

View more
  31 in total

1.  Acute and chronic hyperammonemia modulate antioxidant enzymes differently in cerebral cortex and cerebellum.

Authors:  Santosh Singh; Raj K Koiri; Surendra Kumar Trigun
Journal:  Neurochem Res       Date:  2007-08-04       Impact factor: 3.996

Review 2.  The Nrf2-ARE cytoprotective pathway in astrocytes.

Authors:  Marcelo R Vargas; Jeffrey A Johnson
Journal:  Expert Rev Mol Med       Date:  2009-06-03       Impact factor: 5.600

3.  Antioxidant proteins TSA and PAG interact synergistically with Presenilin to modulate Notch signaling in Drosophila.

Authors:  Michael F Wangler; Lawrence T Reiter; Georgianna Zimm; Jennifer Trimble-Morgan; Jane Wu; Ethan Bier
Journal:  Protein Cell       Date:  2011-08-06       Impact factor: 14.870

Review 4.  Herbal medicines for ischemic stroke: combating inflammation as therapeutic targets.

Authors:  Yong Gu; Jianping Chen; Jiangang Shen
Journal:  J Neuroimmune Pharmacol       Date:  2014-02-22       Impact factor: 4.147

5.  Prostate epithelium-specific deletion of the selenocysteine tRNA gene Trsp leads to early onset intraepithelial neoplasia.

Authors:  H Artee Luchman; Michelle L Villemaire; Tarek A Bismar; Bradley A Carlson; Frank R Jirik
Journal:  Am J Pathol       Date:  2014-01-18       Impact factor: 4.307

Review 6.  Redox regulation of cellular stress response in aging and neurodegenerative disorders: role of vitagenes.

Authors:  Vittorio Calabrese; Eleonora Guagliano; Maria Sapienza; Mariangela Panebianco; Stella Calafato; Edoardo Puleo; Giovanni Pennisi; Cesare Mancuso; D Allan Butterfield; Annamaria Giuffrida Stella
Journal:  Neurochem Res       Date:  2006-12-27       Impact factor: 3.996

Review 7.  Emerging roles of Nrf2 and phase II antioxidant enzymes in neuroprotection.

Authors:  Meijuan Zhang; Chengrui An; Yanqin Gao; Rehana K Leak; Jun Chen; Feng Zhang
Journal:  Prog Neurobiol       Date:  2012-09-29       Impact factor: 11.685

8.  Methylene blue upregulates Nrf2/ARE genes and prevents tau-related neurotoxicity.

Authors:  Cliona Stack; Shari Jainuddin; Ceyhan Elipenahli; Meri Gerges; Natalia Starkova; Anatoly A Starkov; Mariona Jové; Manuel Portero-Otin; Nathalie Launay; Aurora Pujol; Navneet Ammal Kaidery; Bobby Thomas; Davide Tampellini; M Flint Beal; Magali Dumont
Journal:  Hum Mol Genet       Date:  2014-02-20       Impact factor: 6.150

9.  Thioredoxin-interacting protein: a novel target for neuroprotection in experimental thromboembolic stroke in mice.

Authors:  Tauheed Ishrat; Islam N Mohamed; Bindu Pillai; Sahar Soliman; Abdelrahman Y Fouda; Adviye Ergul; Azza B El-Remessy; Susan C Fagan
Journal:  Mol Neurobiol       Date:  2014-06-18       Impact factor: 5.590

10.  Osteo-chondroprogenitor-specific deletion of the selenocysteine tRNA gene, Trsp, leads to chondronecrosis and abnormal skeletal development: a putative model for Kashin-Beck disease.

Authors:  Charlene M Downey; Chelsea R Horton; Bradley A Carlson; Trish E Parsons; Dolph L Hatfield; Benedikt Hallgrímsson; Frank R Jirik
Journal:  PLoS Genet       Date:  2009-08-21       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.